Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial Cancer-Reference-Cited by-同舟云学术

Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial Cancer

Published:2019-02-02 Issue:5 Volume:151 Page:529-538
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Travaglino Antonio¹,Raffone Antonio²^ORCID,Saccone Gabriele²,De Luca Caterina³,Mollo Antonio²,Mascolo Massimo¹,De Placido Giuseppe²,Insabato Luigi¹,Zullo Fulvio²

Affiliation:

1. Anatomic Pathology Unit, Department of Advanced Biomedical Sciences, School of Medicine

2. Gynecology and Obstetrics Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine

3. Molecular Biology Unit, Department of Public Health, School of Medicine, University of Naples Federico II, Naples, Italy

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/151/5/529/28265019/aqy178.pdf

Reference41 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin.,2015

2. A clinically applicable molecular-based classification for endometrial cancers;Talhouk;Br J Cancer.,2015

3. Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective study [published online July 11, 2018];Giampaolino;J Minim Invasive Gynecol.

4. Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma;Gilks;Am J Surg Pathol.,2013

5. Histotype-genotype correlation in 36 high-grade endometrial carcinomas;Hoang;Am J Surg Pathol.,2013

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of prognostic potential of β-catenin and L1CAM expression according to endometrial cancer risk group;Gynecologic Oncology;2024-05

2. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues;Pathology;2023-12

3. Risk-stratification machine learning model using demographic factors, gynaecological symptoms and β-catenin for endometrial hyperplasia and carcinoma: a cross-sectional study;BMC Women's Health;2023-11-27

4. Preoperative serum tissue factor pathway inhibitor‑2 level as a prognostic marker for endometrial cancer;Oncology Letters;2023-09-13

5. β-catenin inhibitors in cancer therapeutics: intricacies and way forward;Bioengineered;2023-09